Search NLS News

The Nobel Prize in Chemistry 2022 is about making difficult processes easier, describes the Royal Swedish Academy of Sciences. “This year’s Prize in Chemistry deals with not overcomplicating matters, instead working with what is easy and simple. Functional molecules can be built even by taking a straightforward route,” says Johan Åqvist, Chair of the Nobel […]

The 9th edition of Nordic Life Science Days offered many discussions, interesting topics, enthusiastic exhibitors, and not least, a pulsating life science atmosphere. Attending NLSDays really made you realize the need for face-to-face meetings and interactions, and despite the ongoing financial and political turbulence in our world, Malmömässan’s visitors brought a feeling of hope and […]

Alligator Bioscience has reported positive safety data from the 900 mg dose cohort in its Phase 1, first-in-human clinical trial with the 4-1BB (CD137) targeting drug candidate, ATOR-1017. ATOR-1017 is being developed as a tumor-directed therapy for advanced/metastatic cancer. The data show that for doses up to 900 mg there were no significant safety concerns […]

The medtech startup, NADMED, reveals the secrets of the human body at a metabolic level. The company’s technology is based on an invention created in Professor Anu Wartiovaara’s team at University of Helsinki. After years of rigorous studies, NADMED presents a solution which allows more profound and faster study of NADs, they describe in a […]

The company has submitted the AMNOG dossier to “The Federal Joint Committee” (G-BA) in Germany. This initiates the commercial launch of Pepaxti (melphalan flufenamide) and thus Germany will be the first market in Europe where the drug is launched, states the company in a press release. “The launch of Pepaxti in Germany is an important […]

Immedica Pharma has announced that RAVICTI has been accepted and granted Priority Review for the New Drug Application (NDA) in China. In April, another submission for RAVICTI Market Authorisation Approval was accepted by the Department of Health (DoH) in HongKong. “With these submissions in China and HongKong, Immedica continues to rapidly bring Ravicti to patients globally. […]

Svante Pääbo receives the Prize for his discoveries concerning the genomes of extinct hominins and human evolution. Svante Pääbo was born 1955 in Stockholm, Sweden. He defended his PhD thesis in 1986 at Uppsala University and was a postdoctoral fellow at University of Zürich, Switzerland and later at University of California, Berkeley, USA. Pääbo became […]

SynAct Pharma has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA), with the aim to commence its Phase 2a/b clinical trial RESOLVE with AP1189 in the United States. “We are happy to announce that we have now submitted the IND to the FDA in line with our previously […]

Annika Szabo has been appointed Managing Director of EIT Health Scandinavia. Annika Szabo has been Interim Managing Director at the organization since December 2021. She began working at EIT Health Scandinavia in December 2018 as Education Lead, responsible for promoting innovative education. She has also worked with the EIT Health project Healthcare Transformation Academy, run by […]

Marjo Puumalainen has been appointed SwedenBIO’s first International Director, as part of the organization’s ongoing efforts to strengthen its representation of Swedish life science on the global arena. “Sweden and the Nordics have positioned ourselves internationally as a strong life science region during the pandemic. As an industry organization, it falls on us at SwedenBIO […]